As of June 14, 2025, Celsion Corp (CLSN) reports a Current Ratio of 7.67.
Current Ratio assesses a company's ability to pay short-term debts by comparing liquid assets to liabilities, with higher ratios signaling better financial health.
Historical Trend of Celsion Corp's Current Ratio
Over recent years, Celsion Corp's Current Ratio has shown significant volatility. The table below summarizes the historical values:
| Date | Current Ratio |
|---|---|
| 2021-12-31 | 7.67 |
| 2020-12-31 | 2.79 |
| 2019-12-31 | 2.06 |
| 2018-12-31 | 4.60 |
| 2017-12-31 | 3.92 |
This slight upward trend highlights how Celsion Corp manages its short-term assets and liabilities over time.
Comparing Celsion Corp's Current Ratio to Peers
To better understand Celsion Corp's position, it's useful to compare its Current Ratio against industry peers. Below are selected comparisons:
| Company | Current Ratio |
|---|---|
| Celsion Corp (CLSN) | 7.67 |
| Heat Biologics Inc (HTBX) | 21.04 |
| IsoRay Inc (ISR) | 19.86 |
| Savara Inc (SVRA) | 13.73 |
| Eledon Pharmaceuticals Inc (ELDN) | 12.42 |
| Bone Biologics Corp (BBLG) | 10.22 |
Compared to its competitors, Celsion Corp's Current Ratio is among the highest compared to peers, indicating strong short-term financial flexibility but potentially excess cash that could be invested.